However, the majority of studies observed a positive correlation between overexpression of cyclin E and poor outcome, including non-Hodgkin's lymphoma (Ferreri et al, 2001) and breast cancer (Keyomarsi et al, 2002). Here, CCNE1 is linked to breast cancer.